Frost MD Amends OPKO Health Stake Filing

TL;DR

Frost MD's group updated their OPKO Health 13D filing - address change for notices.

AI Summary

Phillip Frost MD and others filed an amendment (No. 24) to their Schedule 13D on August 29, 2024, regarding their holdings in OPKO Health, Inc. The filing indicates a change in the reporting person's information, specifically related to the address of the person authorized to receive notices, which is now Camielle Green at OPKO Health, Inc.'s Miami, Florida address.

Why It Matters

This amendment to a Schedule 13D filing signals a change in the administrative details of a significant shareholder's disclosure, potentially impacting how information is communicated regarding their stake in OPKO Health.

Risk Assessment

Risk Level: low — This filing is an administrative amendment and does not appear to indicate a change in beneficial ownership or investment strategy.

Key Players & Entities

• Phillip Frost MD (person) — Reporting Person
• OPKO Health, Inc. (company) — Subject Company
• Camielle Green (person) — Authorized person to receive notices

FAQ

Key Financial Figures

• $0.01 — me of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securiti

Filing Documents

• pfro20240827_sc13da.htm (SC 13D/A) — 98KB
• 0001437749-24-028038.txt ( ) — 99KB

(a)-(d) is deleted in its entirety and replaced with the following text

Item 5 (a)-(d) is deleted in its entirety and replaced with the following text: (a)-(b) Gamma Trust directly beneficially owns 211,232,222 shares of Common Stock. The 211,232,222 total shares of Common Stock beneficially owned by Gamma Trust constitute approximately 30.5% of the Issuer's outstanding shares of Common Stock, based upon (i) 691,986,795 shares of Common Stock outstanding as of August 27, 2024 as communicated by the Issuer to the Reporting Person. Dr. Frost is the sole trustee of Gamma Trust and holds sole voting and dispositive power with respect to 211,232,222 shares of Common Stock. Frost Nevada directly beneficially owns 30,127,177 shares of Common Stock. The 30,127,177 total shares of Common Stock beneficially owned by Frost Nevada constitute approximately 4.4% of the Issuer's outstanding shares of Common Stock, based upon 691,986,795 shares of Common Stock outstanding as of August 27, 2024 as communicated by the Issuer to the Reporting Person. Dr. Frost is the sole trustee of Frost Nevada and holds sole voting and dispositive power with respect to 30,127,177 shares of Common Stock. Dr. Frost, as the sole trustee of Gamma Trust, may be deemed to beneficially own the 211,232,222 shares of Common Stock beneficially owned by Gamma Trust. Dr. Frost, as the sole trustee of Frost Nevada, may be deemed to beneficially own the 30,127,177 shares of Common Stock beneficially owned by Frost Nevada. In addition, the Phillip and Patricia Frost Philanthropic Foundation, Inc., which is controlled by Dr. Frost and his wife, owns 2,851,830 shares of Common Stock. Dr. Frost individually owns 3,068,951 shares of Common Stock and has stock options to acquire 2,800,000 shares of Common Stock, which are exercisable within 60 days of the date hereof, and has sole voting and dispositive power over each. The 250,080,180 shares of Common Stock beneficially owned by Dr. Frost constitute approximately 36.0% of the Issuer's outstanding shares of Common Stock, based upon (i)

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Frost Gamma Investments Trust Dated: August 29, 2024 By: /s/ Phillip Frost, M.D. Name: Phillip Frost, M.D. Title: Sole Trustee Frost Nevada Investments Trust Dated: August 29, 2024 By: /s/ Phillip Frost, M.D. Name: Phillip Frost, M.D. Title: Sole Trustee Dated: August 29, 2024 By: /s/ Phillip Frost, M.D. Name: Phillip Frost, M.D. Title: Phillip Frost, M.D., Individually

View Full Filing

View this SC 13D/A filing on SEC EDGAR